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To sleep or not to sleep during deep brain
stimulation surgery for Parkinson disease?
In functional stereotactic neurosurgery, precise place-
ment of lesions or deep brain stimulation (DBS) elec-
trodes is paramount. From the beginning of the
specialty, electrical stimulation of the brain target
prior to lesioning, and confirmation of accuracy of
targeting by postoperative imaging, have been criti-
cal.1 Two schools subsequently evolved: one using
macroelectrode stimulation in the awake patient with
careful on-table assessment and one using microelec-
trode recording (MER) to map out boundaries of the
target followed by microstimulation to assess efficacy
and avoid side effects. For many, the latter technique
was adopted as the gold standard, but the evidence to
support the superior efficacy or better safety of this
stance was lacking.2
In this issue of Neurology®, Brodsky et al.3 analyze
the 6-month outcome of 30 patients who underwent
asleep DBS without MER but with intraoperative
imaging verification of targeting accuracy, compared
to 39 who underwent awake MER-guided DBS. In
the asleep DBS group, 7 were implanted in the sub-
thalamic nucleus (STN) and 23 in the globus pallidus
pars interna (GPi). In the awake MER-guided DBS
group. 18 were in STN and 21 in GPi. The asleep
patients had intraoperative CT scan to verify the elec-
trode location. The improvement was the same in
both groups concerning Unified Parkinson’s Disease
Rating Scale (UPDRS) III as well as UPDRS II and
“on” time without dyskinesias. The improvement in
the summary index of the 39-item Parkinson’s Dis-
ease Questionnaire, and in subscores for cognition
and communication, were better in the asleep DBS
group. The outcome of speech was also better in the
asleep than in the awake group. The authors con-
cluded that asleep DBS improves motor outcome
similar to, or better than, awake DBS.
A possible limitation of this study is that the
groups of awake and asleep patients were not random-
ized and the comparison was between a historical
cohort of patients who had DBS surgery awake with
a more recent cohort who had surgery asleep. How-
ever, as the authors pointed out, it would have been
difficult to recruit patients in order to randomize
between awake and asleep. On the other hand, the
strength of this study is that it reflects the experience
of a single center and a single neurosurgeon: to add to
the importance of this article, it is worth noting that
the surgeon is one of the pioneers and a proponent of
MER in North America and in 2004 edited a compre-
hensive book to that effect.4
In that book, the senior editor asked the following:
1. Does MER add demonstrable value to movement
disorder surgery?
2. Does MER add risk to movement disorder sur-
gery, and if so, what is the risk/benefit ratio?
Now, 13 years later, the article at hand by the
same author answers the first question above: MER
did not add demonstrable value to movement disor-
ders surgery.
As for the second question, the authors discuss the
wealth of data available in the literature showing that
MER may increase the risk of hemorrhage compared
to functional stereotactic neurosurgery—whether
ablative procedure or DBS—performed without
MER.5,6 Furthermore, the costs with MER surgery
are higher.7 Finally, the use of MER in awake patients
may not be a sufficient guarantee for an accurate
placement of the DBS electrode in the intended brain
target: in a recent publication, looking at Medicare
and National Surgical Quality Improvement Program
records of 28,179 DBS procedures, with MER guid-
ance, revision rates for implants could vary from
15.2% to 34%.8 On the other hand, immediate intra-
operative or postoperative stereotactic imaging does
provide the means to verify that the DBS electrode
has indeed reached the intended target.
The role of stereotactic imaging. Regardless of MER-
awake DBS or non-MER asleep DBS, the most
important verdict as to the accuracy of stereotactic
targeting is the verification of hitting the targeted
structure. The advances in MRI in the last decade
have enabled visualization of the STN and the GPi in
an individual patient, obviating the need for an atlas.
Before these advances were made, radiologic stereo-
tactic guidance was not altogether reliable (due to
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MRI distortion problems and CT visualization
shortcomings) and therefore MER was necessary. The
ongoing need for MER is also questionable with
additional advances in image fusion algorithms.
Availability of either an MRI machine or a dedicated
CT machine in the operating room have made it
possible to perform stereotactic imaging immediately
after placement of the electrodes to verify the accuracy
of targeting in the operating room, ensuring targeting
accuracy before the surgery is finished. Hence, if the
target can be readily visualized on stereotactic MRI
and if the DBS electrodes—in relation to the target—
can also be readily visualized on imaging in stereo-
tactic space, and of course if the surgeon is confident
in stereotactic functional neurosurgery and in detailed
anatomy of the target structure and its surroundings,
why would there be a need for awake surgery, with or
without MER?
The second question is, if one can perform accu-
rate electrode placement and verify the targeting accu-
racy on imaging alone, does the patient need to be
awake?
Eliminating MER will reduce risks without
compromising outcomes, shorten the procedure
duration, and reduce its costs. Asleep surgery is cer-
tainly better for patients, who will not need to be
“off” medications for several hours prior to, and
several hours during, the surgery.9 In fact, asleep
DBS, provided experience in modern stereotactic
imaging, both before and especially immediately
after the procedure, is gaining momentum even
in centers that previously used MER-awake DBS
surgery.10 However, performing surgery in asleep
patients precludes the ability to determine clinical
benefit/side effects from macrostimulation and
therefore somewhat tempers adoption of asleep sur-
gery in even the best circumstances (for example,
with an intraoperative MRI suite).
Thus the following question arises: Is there a gold
standard and is it the use of MER and awake DBS
surgery? The modern gold standard of DBS surgery
seems to be more a confirmation of electrode place-
ment before the procedure is finished, whatever tech-
nique and whatever mode of anesthesia is used. MER
would thus be reserved to where it best belongs: as
a tool for scientific research on basal ganglia neuronal
activity.
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